vs
Side-by-side financial comparison of CAMDEN NATIONAL CORP (CAC) and MEDIFAST INC (MED). Click either name above to swap in a different company.
MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $64.3M, roughly 1.2× CAMDEN NATIONAL CORP). Over the past eight quarters, CAMDEN NATIONAL CORP's revenue compounded faster (22.6% CAGR vs -34.4%).
Camden National Bank is a commercial bank headquartered in Camden, Maine, operating as the principal subsidiary of Camden National Corporation, a publicly traded bank holding company. Founded in 1875, the bank became a direct, wholly owned subsidiary of the holding company following a corporate reorganization in 1984. Following the 2025 merger with Northway Financial, the combined institution has approximately $7.0 billion in assets.
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
CAC vs MED — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $64.3M | $75.1M |
| Net Profit | $21.9M | — |
| Gross Margin | — | 69.4% |
| Operating Margin | — | -10.4% |
| Net Margin | 34.0% | — |
| Revenue YoY | — | -36.9% |
| Net Profit YoY | — | — |
| EPS (diluted) | $1.29 | $-1.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $64.3M | — | ||
| Q4 25 | $68.1M | $75.1M | ||
| Q3 25 | $65.4M | $89.4M | ||
| Q2 25 | $62.3M | $105.6M | ||
| Q1 25 | $60.1M | $115.7M | ||
| Q4 24 | $47.6M | $119.0M | ||
| Q3 24 | $45.0M | $140.2M | ||
| Q2 24 | $42.8M | $168.6M |
| Q1 26 | $21.9M | — | ||
| Q4 25 | $22.6M | — | ||
| Q3 25 | $21.2M | $-2.3M | ||
| Q2 25 | $14.1M | $2.5M | ||
| Q1 25 | $7.3M | $-772.0K | ||
| Q4 24 | $14.7M | — | ||
| Q3 24 | $13.1M | $1.1M | ||
| Q2 24 | $12.0M | $-8.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | 69.4% | ||
| Q3 25 | — | 69.5% | ||
| Q2 25 | — | 72.6% | ||
| Q1 25 | — | 72.8% | ||
| Q4 24 | — | 74.1% | ||
| Q3 24 | — | 75.4% | ||
| Q2 24 | — | 73.2% |
| Q1 26 | — | — | ||
| Q4 25 | 41.5% | -10.4% | ||
| Q3 25 | 40.5% | -4.6% | ||
| Q2 25 | 28.5% | -1.0% | ||
| Q1 25 | 10.3% | -1.1% | ||
| Q4 24 | 38.7% | 0.6% | ||
| Q3 24 | 35.2% | 1.5% | ||
| Q2 24 | 34.7% | -4.7% |
| Q1 26 | 34.0% | — | ||
| Q4 25 | 33.1% | — | ||
| Q3 25 | 32.4% | -2.5% | ||
| Q2 25 | 22.6% | 2.3% | ||
| Q1 25 | 12.2% | -0.7% | ||
| Q4 24 | 30.8% | — | ||
| Q3 24 | 29.1% | 0.8% | ||
| Q2 24 | 28.0% | -4.8% |
| Q1 26 | $1.29 | — | ||
| Q4 25 | $1.33 | $-1.64 | ||
| Q3 25 | $1.25 | $-0.21 | ||
| Q2 25 | $0.83 | $0.22 | ||
| Q1 25 | $0.43 | $-0.07 | ||
| Q4 24 | $1.00 | $0.08 | ||
| Q3 24 | $0.90 | $0.10 | ||
| Q2 24 | $0.81 | $-0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $167.3M |
| Total DebtLower is stronger | $514.4M | — |
| Stockholders' EquityBook value | $710.0M | $198.9M |
| Total Assets | $7.0B | $248.0M |
| Debt / EquityLower = less leverage | 0.72× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $167.3M | ||
| Q3 25 | — | $173.5M | ||
| Q2 25 | — | $162.7M | ||
| Q1 25 | — | $164.6M | ||
| Q4 24 | — | $162.3M | ||
| Q3 24 | — | $170.0M | ||
| Q2 24 | — | $163.5M |
| Q1 26 | $514.4M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $710.0M | — | ||
| Q4 25 | $696.6M | $198.9M | ||
| Q3 25 | $676.4M | $214.7M | ||
| Q2 25 | $652.1M | $216.0M | ||
| Q1 25 | $640.1M | $211.0M | ||
| Q4 24 | $531.2M | $210.1M | ||
| Q3 24 | $529.9M | $207.3M | ||
| Q2 24 | $508.3M | $205.3M |
| Q1 26 | $7.0B | — | ||
| Q4 25 | $7.0B | $248.0M | ||
| Q3 25 | $7.0B | $268.2M | ||
| Q2 25 | $6.9B | $269.3M | ||
| Q1 25 | $7.0B | $280.0M | ||
| Q4 24 | $5.8B | $284.2M | ||
| Q3 24 | $5.7B | $291.2M | ||
| Q2 24 | $5.7B | $293.5M |
| Q1 26 | 0.72× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-5.3M |
| Free Cash FlowOCF − Capex | — | $-6.6M |
| FCF MarginFCF / Revenue | — | -8.8% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $63.9M | $-5.3M | ||
| Q3 25 | $36.1M | $12.1M | ||
| Q2 25 | $6.0M | $-3.4M | ||
| Q1 25 | $1.0M | $3.4M | ||
| Q4 24 | $60.9M | $-4.9M | ||
| Q3 24 | $-14.5M | $9.1M | ||
| Q2 24 | $14.5M | $13.1M |
| Q1 26 | — | — | ||
| Q4 25 | $58.2M | $-6.6M | ||
| Q3 25 | $35.4M | $10.8M | ||
| Q2 25 | $4.5M | $-4.8M | ||
| Q1 25 | $-727.0K | $1.9M | ||
| Q4 24 | $55.4M | $-7.2M | ||
| Q3 24 | $-16.2M | $7.7M | ||
| Q2 24 | $13.2M | $11.1M |
| Q1 26 | — | — | ||
| Q4 25 | 85.5% | -8.8% | ||
| Q3 25 | 54.1% | 12.0% | ||
| Q2 25 | 7.3% | -4.5% | ||
| Q1 25 | -1.2% | 1.6% | ||
| Q4 24 | 116.4% | -6.1% | ||
| Q3 24 | -36.0% | 5.5% | ||
| Q2 24 | 30.8% | 6.6% |
| Q1 26 | — | — | ||
| Q4 25 | 8.4% | 1.8% | ||
| Q3 25 | 1.1% | 1.5% | ||
| Q2 25 | 2.4% | 1.3% | ||
| Q1 25 | 2.9% | 1.3% | ||
| Q4 24 | 11.7% | 1.9% | ||
| Q3 24 | 3.8% | 1.0% | ||
| Q2 24 | 3.0% | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | 2.83× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 0.43× | -1.36× | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | 4.15× | — | ||
| Q3 24 | -1.11× | 8.04× | ||
| Q2 24 | 1.21× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CAC
| Net Interest Income | $52.4M | 81% |
| Noninterest Income | $12.0M | 19% |
MED
Segment breakdown not available.
